Efficacy and safety of nivolumab with ipilimumab for recurrent malignant pleural mesothelioma after primary surgical intervention.
Int J Clin Oncol
; 28(3): 409-415, 2023 Mar.
Article
in En
| MEDLINE
| ID: mdl-36609928
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Mesothelioma, Malignant
Limits:
Humans
Language:
En
Journal:
Int J Clin Oncol
Journal subject:
NEOPLASIAS
Year:
2023
Document type:
Article
Affiliation country:
Japón
Country of publication:
Japón